0001562180-24-000608.txt : 20240125 0001562180-24-000608.hdr.sgml : 20240125 20240125160346 ACCESSION NUMBER: 0001562180-24-000608 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240124 FILED AS OF DATE: 20240125 DATE AS OF CHANGE: 20240125 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cavalie Fanny CENTRAL INDEX KEY: 0001913484 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39634 FILM NUMBER: 24562161 MAIL ADDRESS: STREET 1: C/O FOGHORN THERAPEUTICS INC. STREET 2: 500 TECHNOLOGY SQUARE, SUITE 700 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Foghorn Therapeutics Inc. CENTRAL INDEX KEY: 0001822462 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 TECHNOLOGY SQUARE STREET 2: SUITE 700 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-586-3100 MAIL ADDRESS: STREET 1: 500 TECHNOLOGY SQUARE STREET 2: SUITE 700 CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 primarydocument.xml PRIMARY DOCUMENT X0508 4 2024-01-24 false 0001822462 Foghorn Therapeutics Inc. FHTX 0001913484 Cavalie Fanny 500 TECHNOLOGY SQUARE STE #700 CAMBRIDGE MA 02139 false true false false Chief Strategy/Bus Ops Officer false Stock Option (right to buy) 3.06 2024-01-24 4 A false 80000.00 3.06 A 2034-01-23 Common Stock 80000.00 80000.00 D The option vests as to 25% of the underlying shares of common stock on January 24, 2025, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter. /s/ Michael LaCascia, Attorney-in-Fact for Fanny Cavalie 2024-01-25